As part of our mission to eliminate cancer, MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers. Look through our database to find studies for which you may be eligible.
Project ECHO® (Extension for Community Healthcare Outcomes) is a teleconsulting and telementoring partnership between MD Anderson specialists and providers in rural and underserved communities.
Sometimes, patients ask me about IV vitamin therapy after reading testimonials online from people who claim it has helped them feel better, or that it can ease the side effects of cancer treatments, such as nausea caused by chemotherapy.
Be among the best and brightest in cancer care and research
Measurable residual disease (MRD) is a monitoring tool that physicians use to assess the remission status of patients with leukemias, lymphomas, myelomas and other blood disorders.
You’ve finished your cancer treatment and shown no evidence of disease — for weeks, months or maybe even years. Then, a routine scan or bloodwork reveals something concerning. Your doctor thinks the cancer might have returned. So, what do you do now?
THE IDEAL CHOICE FOR EDUCATION & TRAINING IN THE BIOMEDICAL SCIENCES
62 NCI-designated cancer centers, leading national organizations and the University of Puerto Rico Comprehensive Cancer Center jointly endorse statement
MD Anderson academic programs are competitive and comprehensive. We offer educational opportunities from undergraduate degrees to advanced nursing education.
Shop MD Anderson Show your support for our mission through branded merchandise.
